다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Schizophrenia research, v.114 no.1/3, 2009년, pp.98 - 104
Manning, Victoria (National Addiction Centre, Maudsley Hospital) , Betteridge, Shai (City and Hackney NHS Community Services, Top Floor E Block, St Leonard's Hospital, Nuttall Street, London, N1 5LZ, UK) , Wanigaratne, Shamil (National Addiction Centre, Maudsley Hospital) , Best, David (Criminal Justice Research Centre, Room 822A,University of the West of Scotland, Hamilton Campus, Almada Street, Hamilton, Lanarkshire ML3 0JB, UK) , Strang, John (National Addiction Centre, Maudsley Hospital) , Gossop, Michael (National Addiction Centre, Maudsley Hospital)
AI-Helper
AbstractCognitive impairment has been found independently among individuals with schizophrenia and individuals with alcohol use disorders. Less is known about the nature and severity of cognitive impairment in patients with a dual diagnosis, though the co-occurrence of these disorders may further ex...
Neuropsychology. Allen 13 62 1999 10.1037/0894-4105.13.1.62 Neurocognitive dysfunction in patients diagnosed with schizophrenia and alcoholism
Neuropsychiatry Neuropsychol Behav Neurol. Allen 13 184 2000 Neurologic examination abnormalities in schizophrenia with and without a history of alcoholism
Br J Psychiatry. Barnes 177 207 2006 10.1192/bjp.177.3.207 West London first-episode study of schizophrenia. Clinical correlates of duration of untreated psychosis
Exp Clin Psychopharmacol. Bates 10 193 2002 10.1037/1064-1297.10.3.193 Neurocognitive impairment associated with alcohol use disorders: implications for treatment
Neuropsychologia Benton 6 53 1968 10.1016/0028-3932(68)90038-9 Differential behavioural effects in frontal lobe disease
Am J Psychiatry Bilder 157 549 2000 10.1176/appi.ajp.157.4.549 Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates
Schizophr Bull. Bowie 31 175 2005 10.1093/jschbul/sbi001 Neurocognition, symptomatology, and functional skills in older alcohol-abusing schizophrenia patients
Burgess 1997 The Hayling and Brixton Tests
J Int Neuropsychol Soc. Burgess 4 6 547 1998 10.1017/S1355617798466037 The ecological validity of tests of executive function
CANTAB 1999 Cambridge Neuropsychological Test Automated Battery
Schizophr. Res. Cantor-Graae 48 69 2001 10.1016/S0920-9964(00)00114-6 Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden
Acta Psychiatr Scand. Carlsson 113 102 2006 10.1111/j.1600-0447.2005.00661.x Neuropsychological functions predict 1- and 3-year outcome in first-episode psychosis
Br J Psychiatry. Cantwell 174 150 1999 10.1192/bjp.174.2.150 Prevalence of substance misuse in first-episode psychosis
J Nerv Mental Dis, Carey 191 300 2003 10.1097/01.NMD.0000066152.87832.A9 Correlates of substance use disorder among psychiatric outpatients: focus on cognition, social role functioning, and psychiatric status
Hosp Community Psychiatry. Drake 40 1041 1989 Substance abuse among the chronic mentally ill
Eur Arch Psychiatry Clin Neurosci. Eberhard 253 2 84 2003 10.1007/s00406-003-0412-y Premorbid IQ and schizophrenia. Increasing cognitive reduction by episodes
Evans 2003 Clinical Neuropsychology. A Practical Guide to Assessment and Management for Clinicians. Basic concepts and principles of neuropsychological assessment
Schizophr Bull. Fowler 24 3 443 1998 10.1093/oxfordjournals.schbul.a033339 Patterns of current and lifetime substance use in schizophrenia
J Consult Clin Psychol. Grant 55 310 1987 10.1037/0022-006X.55.3.310 Alcohol and the brain: neuropsychological correlates
Schizophr Bull. Green 26 119 2000 10.1093/oxfordjournals.schbul.a033430 Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the “right stuff”?
Psychol Med. Harrison 29 1 2007 Naturalistic follow-up study of comorbid substance use in schizophrenia: the West London first episode study
Arch Gen Psychiatry. Heaton 58 24 2001 10.1001/archpsyc.58.1.24 Stability and course of neuropsychological deficits in schizophrenia
Int J Ment Health Nurs. Herman 13 282 2004 10.1111/j.1440-0979.2004.00346.x Neurocognitive functioning and quality of life among dually diagnosed and non-substance abusing schizophrenia inpatients
Curr Opin Psychiatry Hoff 16 149 2003 10.1097/00001504-200303000-00003 Neuropsychology in schizophrenia: an update
J Forensic Psychiatr. Isherwood 12 446 2001 10.1080/09585180110057154 Prevalence and severity of substance misuse among referrals to a local forensic service
Schizophr. Res. Joyal 63 297 2003 10.1016/S0920-9964(02)00387-0 Drug abuse and/or dependence and better neuropsychological performance in patients with schizophrenia
Acta Psychiatr Scand. Kastrup 76 80 1987 10.1111/j.1600-0447.1987.tb02865.x Who became revolving door patients? Findings from a nationwide cohort of first time admitted psychiatric patients
Psychol Med. Krabbendam 33 4 756 2003 Meta-analyses of randomized controlled trials of social skills training and cognitive remediation
Schizophr. Res. Manning 91 151 2007 10.1016/j.schres.2006.11.019 Screening for cognitive functioning in psychiatric outpatients with schizophrenia, alcohol dependence, and dual diagnosis
Eur Addict Res. Manning 14 226 2008 10.1159/000156479 Impairment and recovery of neuropsychological functioning during medically-assisted inpatient alcohol withdrawal
Marlatt 1985 Relapse Prevention: Maintenance Strategies in the Treatment of Addictive Behaviours
Addiction. Marsden 93 1857 1998 10.1046/j.1360-0443.1998.9312185711.x The Maudsley Addiction Profile (MAP): a brief instrument for assessing treatment outcome
Am J Psychiatry. McGurk 164 1791 2007 10.1176/appi.ajp.2007.07060906 A meta-analysis of cognitive remediation in schizophrenia
Neuropsychopharmacology. Meltzer 14 27 1996 10.1016/0893-133X(95)00202-O Neuropsychologic deficits in schizophrenia: relation to social function and effect of antipsychotic drug treatment
Br J Psychiatry. Menezes 168 612 1996 10.1192/bjp.168.5.612 Drug and alcohol problems among individuals with severe mental illness in south London
Psychiatr Serv. Miles 54 554 2003 10.1176/appi.ps.54.4.554 Characteristics of subgroups of individuals with psychotic illness and a co-morbid substance use disorder
Int J Geriatr Psychiatry. Mohamed 21 711 2006 10.1002/gps.1528 Neurocognitive functioning in dually diagnosed middle aged and elderly patients with alcoholism and schizophrenia
Nelson 1991 National Adult Reading Test (NART Test Manual)
Psychiatry Res. Nixon 64 35 1996 10.1016/0165-1781(96)02911-3 Neurocognitive function in alcoholic, schizophrenic, and dually diagnosed patients
Br Med J. Piccinelli 314 420 1997 10.1136/bmj.314.7078.420 Efficacy of the alcohol use disorders identification test as a screening tool for hazardous alcohol intake and related disorders in primary care: a validity study
Brain Cogn. Potvin 59 38 2005 10.1016/j.bandc.2005.04.002 CANTAB explicit memory is less impaired in addicted schizophrenia patients
Schizophr. Res. Potvin 100 242 2008 10.1016/j.schres.2007.04.022 Contradictory cognitive capacities among substance-abusing patients with schizophrenia: a meta-analysis
Schizophr. Res. Salyers 48 109 2001 10.1016/S0920-9964(00)00063-3 Social functioning, psychopathology, and medication side effects in relation to substance use and abuse in schizophrenia
J Clin Psychiatry. Sheenan 59 34 1998 The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10
Schizophr Bull. Silverstein 35 222 2009 10.1093/schbul/sbm150 Attention shaping: a reward-based learning method to enhance skills training outcomes in schizophrenia
J Nerv Mental Dis. Smelson 190 200 2002 10.1097/00005053-200203000-00010 Executive and motor skill functioning among cocaine-dependent schizophrenics and non-drug-abusing schizophrenics
Addict Behav. Teichner 27 751 2002 10.1016/S0306-4603(01)00207-6 Substance abuse treatment outcomes for cognitively impaired and intact outpatients
Psychol Rev. Tiffany 97 2 147 1990 10.1037/0033-295X.97.2.147 A cognitive model of drug urges and drug-use behavior: role of automatic and nonautomatic processes
Int J Methods Psychiatr Res. Ventura 3 221 1993 Training and quality assurance with the Brief Psychiatric Rating Scale: ‘The Drift Busters’
Drug Alcohol Rev. Weaver 20 407 2001 10.1080/09595230120092724 The prevalence and management of co-morbid substance misuse and mental illness: results of a screening survey in substance misuse and mental health treatment population
Wechsler 1997 Wechsler Memory Scale - Third Edition (WMS-III) Administration and Scoring Manual
Wechsler 1999 Wechsler Abbreviated Scale of Intelligence (WASI)
J Forensic Psychiatr. Wheatley 9 114 1998 10.1080/09585189808402182 The prevalence and relevance of substance use in detained schizophrenic patients
World Health Organization 2001 Disability Assessment Schedule II (WHODAS II). URL
Soc Psychiatry Psychiatr Epidemiol. Wright 35 297 2000 10.1007/s001270050242 Dual diagnosis in the suburbs: prevalence, need, and in-patient service use
Br J Psychiatry. Wykes 181 144 2002 Effects on the brain of a psychological treatment: cognitive remediation therapy: functional magnetic resonance imaging in schizophrenia
Schizophr. Res. Wykes 61 163 2003 10.1016/S0920-9964(02)00239-6 Are the effects of cognitive remediation therapy (CRT) durable? Results from an exploratory trial in schizophrenia
Zigmond 67 361 1983
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.